Financial Statements — LXEO
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 |
|---|
| Cash & Equivalents | 92.83 | 71.77 | 41.00 | 35.48 | 28.91 | 157.02 | 174.98 | 195.06 | 35.45 |
| Short-term Investments | -- | -- | -- | -- | 70.92 | -- | -- | -- | -- |
| Total Current Assets | 217.91 | 200.86 | 127.79 | 140.06 | 105.27 | 159.46 | 177.15 | 198.09 | 38.87 |
| Property, Plant & Equipment | 1.12 | 1.10 | 1.23 | 1.12 | 1.05 | 1.18 | 1.21 | 1.04 | 0.98 |
| Total Non-current Assets* | 36.99 | 49.49 | 16.05 | 36.01 | 20.42 | 14.41 | 14.86 | 15.12 | 15.85 |
| Total Assets | 254.90 | 250.36 | 143.84 | 176.07 | 125.69 | 173.87 | 192.01 | 213.21 | 54.72 |
| Accounts Payable | 4.18 | 3.34 | 4.66 | 20.02 | 11.98 | 8.44 | 5.77 | 4.30 | 2.66 |
| Total Current Liabilities | 15.69 | 14.19 | 17.27 | 31.59 | 30.82 | 26.82 | 18.88 | 21.63 | 23.04 |
| Total Non-current Liabilities* | 4.14 | 4.67 | 5.74 | 6.26 | 6.75 | 7.72 | 8.18 | 8.63 | 9.46 |
| Total Liabilities | 19.84 | 18.86 | 23.01 | 37.85 | 37.58 | 34.54 | 27.06 | 30.26 | 32.50 |
| Retained Earnings | (426.20) | (400.33) | (359.21) | (338.93) | (312.83) | (254.25) | (224.76) | (203.52) | (167.65) |
| Total Stockholder Equity | 235.06 | 231.50 | 120.83 | 138.22 | 88.12 | 139.33 | 164.95 | 182.95 | (162.81) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 |
|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.53 |
| Research & Development | 19.03 | 15.70 | 16.21 | 15.70 | 14.72 | 17.17 | 18.37 | 23.42 | 16.56 | 15.74 | 8.21 | 17.25 |
| Selling, General & Admin | 8.99 | 6.63 | 6.91 | 5.95 | 15.97 | 16.63 | 9.02 | 8.12 | 6.99 | 7.55 | 6.76 | 3.03 |
| Total Operating Expenses | 28.02 | 22.33 | 23.12 | 21.65 | 30.69 | 33.81 | 27.38 | 31.54 | 23.55 | 23.29 | 14.97 | 20.27 |
| Operating Income | (28.02) | (22.33) | (23.12) | (21.65) | (30.69) | (33.80) | (27.38) | (31.54) | (23.55) | (23.29) | (14.97) | (20.27) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | 0.04 | 0.04 | 0.05 | 0.05 |
| Pretax Income | (25.87) | (20.20) | (20.63) | (20.28) | (26.10) | (32.66) | (25.92) | (29.49) | (21.24) | (21.68) | (14.19) | (20.11) |
| Net Income | (25.87) | (20.20) | (20.92) | (20.28) | (26.10) | (32.66) | (25.92) | (29.49) | (21.24) | (21.68) | (14.19) | (20.11) |
| Basic EPS | (0.30) | (0.25) | 0.06 | (0.33) | (0.60) | (0.99) | (0.79) | (0.89) | (0.64) | (0.77) | 19.84 | (12.36) |
| Diluted EPS | (0.30) | (0.25) | 0.06 | (0.33) | (0.60) | (0.99) | (0.79) | (0.89) | (0.64) | (0.77) | 19.84 | (12.36) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 |
|---|
| Operating Cash Flow | (17.60) | (21.14) | (20.08) | (29.55) | (27.22) | (21.72) | (28.33) | (17.81) | (20.15) | (14.87) | (13.98) | (45.51) |
| Capital Expenditures | 0.01 | 0.04 | 0.00 | 0.29 | 0.11 | -- | 0.00 | 0.08 | 0.21 | 0.19 | 0.07 | 0.04 |
| Free Cash Flow* | (17.60) | (21.18) | (20.08) | (29.84) | (27.33) | -- | (28.33) | (17.89) | (20.36) | (15.05) | (14.05) | (45.56) |
| Investing Cash Flow | 14.26 | 27.46 | (101.69) | 35.01 | (39.17) | 15.60 | (93.58) | (0.08) | (0.22) | (0.19) | (0.07) | (0.09) |
| Financing Cash Flow | 24.40 | 2.45 | 143.77 | 0.05 | 72.96 | 0.01 | (0.10) | (0.07) | 0.29 | 88.65 | 100.07 | 3.72 |
* Derived from reported values
